GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC ASSESSMENT REPORTS FOR APPROVED MEDICINES
GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC ASSESSMENT REPORTS FOR APPROVED MEDICINES
GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC ASSESSMENT REPORTS FOR APPROVED MEDICINES
Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets _ Public assessment summary report_Package label
PASURTA (erenumab) 140 mg per mL _ SUMMARY OF PRODUCT CHARACTERISTICS
PASURTA (erenumab) 140 mg per mL _ Public assessment summary report_Package label
Magnesium sulfate-Kalceks 500 mg per ml solution for injection_SUMMARY OF PRODUCT CHARACTERISTICS
OCTANATE 500 and OCTANATE 1000 _SUMMARY OF PRODUCT CHARACTERISTICS
OCTANATE 500 and OCTANATE 1000 _ Public assessment summary report
Utrogestan Vaginal 100 mg and 200 mg Soft capsules _ Public assessment summary report_Package label
Utrogestan Vaginal 100 mg and 200 mg Soft capsules_SUMMARY OF PRODUCT CHARACTERISTICS